Notice regarding Acquisition of Additional Shares to make Medica Asia a Wholly Owned Subsidiary and Borrowing of Funds

September 27, 2018

 SMS CO., LTD. (“SMS”) hereby announces that, on September 27, 2018, its Board of Directors has resolved to acquire all of the shares of Medica Asia (Holdco) Limited (“Medica Asia”, Registered Office: UK), a consolidated subsidiary of SMS, and borrow funds to finance the consideration payable in the acquisition as follows.

1.Reason for share acquisition

 With the Group mission of “We create values and contribute to society by providing an information infrastructure for an aging society”, SMS provides more than 40 services in Elderly Care, Medical Care, Healthcare and Senior Life domains in Japan and abroad, including career business such as recruiting agent service, management support service for elderly care operators (Kaipoke) and drug information service.

 SMS, together with MITSUI & CO., LTD. (“MITSUI”), acquired MIMS Group with Medica Asia as a holding company in October 2015 and has been offering services in 15 countries and regions mainly in Asia and Oceania, which forms the core part of SMS Group’s overseas operations. The MIMS brand, established in 1963, has a history of more than 50 years and boasts tremendous name recognition in the region, with approximately 2.3 million registered memberships of healthcare professionals. By leveraging MIMS’s overwhelming brand power, the strong member base of healthcare professionals and the business relationships with pharmaceutical companies and medical institutions, MIMS is operating businesses such as marketing support service for pharmaceutical companies. Since acquiring MIMS Group, SMS has been working on structural reform of MIMS’s existing businesses as well as building a foundation for growth. In addition, MIMS started global career business from 2017 by taking advantage of its member base of healthcare professionals and SMS’s expertise in career-related businesses.

 After deliberate considerations, SMS decided to make Medica Asia a wholly-owned subsidiary in order to accelerate growth by improving agility in decision-making and realizing greater synergies within SMS Group.
 MIMS will maintain cooperative relationships with MITSUI and continue to provide services, such as drug information services and career-related services, to MITSUI’s hospital groups.

2.Outline of Medica Asia

(1) Company Name Medica Asia (Holdco) Limited
(2) Registered Office 6th Floor 65 Gresham Street London EC2V 7NQ
(3) Name and Title of Representative Natsuki Goto, Director
(4) Business Activities Holding company
(5) Share Capital GBP 127.50
(6) Established February, 2013
(7) Shareholders and their Ownership SMS CO., LTD. 60.0%
MITSUI & CO., LTD. 40.0%



3.Outline of MITSUI

(1) Company Name MITSUI & CO., LTD.
(2) Registered Office 1-3, Marunouchi 1-chome, Chiyoda-ku, Tokyo
(3) Name and Title of Representative Tatsuo Yasunaga, President and Chief Executive Officer
(4) Business Activities General trading company
(5) Share Capital JPY 341,481 Million


4.Number of shares to be acquired, acquisition price and state of share ownership before and after transaction

(1) Number of Shares held before the Transaction 7,650,316 shares
(2) Number of Shares to be Acquired 5,100,210 shares
(3) Acquisition Price JPY 11 Billion (Approximate amount)
(4) Number of Shares held after the Transaction 12,750,526 shares


5.Schedule

(1) Date of Board Resolution September 27, 2018
(2) Date of Transfer Agreement September 27, 2018
(3) Date of Share Acquisition September 28, 2018


6.Details of the borrowing

 SMS has entered into a syndicated loan agreement with Sumitomo Mitsui Banking Corporation acting as arranger and agent.
(1) Lender Sumitomo Mitsui Banking Corporation
MUFG Bank, Ltd.
Mizuho Bank, Ltd.
(2) Loan Amount JPY 11 Billion
(3) Date of Execution September 28, 2018
(4) Borrowing Period 10 years
(5) Security Unsecured and unguaranteed


7.Future outlook

 This share acquisition and the borrowing of funds will have only minor effects on SMS’s consolidated financial results.




Notice regarding Acquisition of Additional Shares to make Medica Asia a Wholly Owned Subsidiary and Borrowing of Funds